Form 4: Atara Biotherapeutics CEO Pascal Touchon Reports Option Cancellations
SEC Form 4 Filing
Pascal Touchon, CEO of Atara Biotherapeutics, reports the cancellation of employee stock options and a forthcoming cash payment of $100 in exchange.
Summary
- This Form 4 filing details changes in beneficial ownership for Pascal Touchon, the President and CEO of Atara Biotherapeutics, Inc.
- The report indicates the cancellation of three employee stock option grants.
- These options had exercise prices of $510.75, $303.75, and $427.63.
- The cancellations occurred on August 12, 2024.
- In exchange for the cancellation of these options, Touchon will receive a total cash payment of $100.
- The options were originally granted with vesting schedules starting in June 2020, April 2020, and April 2021, respectively.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing executive stock option cancellations, which is neither inherently positive nor negative.
Positives
- The cancellation of the options simplifies Touchon's equity compensation structure.
Negatives
- The cancellation of the options may indicate a change in the company's compensation strategy or Touchon's role.
Risks
- Changes in executive compensation can sometimes signal internal issues or strategic shifts within a company.
Industry Context
Changes in executive compensation are common in the biopharmaceutical industry, often tied to performance or strategic realignments.
Stakeholder Impact
- Shareholders may be interested in the reasons behind the stock option cancellations and the potential impact on executive incentives.
Key Dates
| Date | Description |
|---|---|
| June 24, 2020 | Initial vesting date for one of the cancelled stock options. |
| April 1, 2020 | Initial vesting date for one of the cancelled stock options. |
| April 1, 2021 | Initial vesting date for one of the cancelled stock options. |
| August 12, 2024 | Date of the stock option cancellations. |
| August 14, 2024 | Date of the Form 4 filing. |
| June 24, 2029 | Expiration date of one of the cancelled stock options. |
| February 28, 2030 | Expiration date of one of the cancelled stock options. |
| February 28, 2031 | Expiration date of one of the cancelled stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.